Introduction
Brand name: Quitcal Total
Company / Division: Essendon Formulation Division (under Astemax Biotech Pvt. Ltd.)
Composition per unit (tablet/softgel):
Cissus quadrangularis 500 mg
Calcium citrate malate 500 mg
Vitamin K2‑7 (Menaquinone‑7) 45 mcg
Quitcal Total is a bone‑health and joint‑support formulation designed to promote fracture healing, bone‑mineralization, and connective‑tissue integrity. Cissus quadrangularis (Hadjod) is an Ayurvedic bone‑healing herb reported to accelerate callus formation, reduce pain and swelling at fracture sites, and support bone‑remodeling processes. Calcium citrate malate provides bioavailable calcium for bone‑matrix formation and maintenance, while vitamin K2‑7 helps direct calcium into bone and reduces risk of vascular calcification.
Key benefits
Supports fracture healing and osteoporosis‑risk management in adults, especially post‑fracture, geriatric, and post‑menopausal patients.
Promotes joint and musculoskeletal comfort by reducing pain‑like perception and supporting cartilage‑bone interface health.
Complements other bone‑health regimens (vitamin D, calcium, bisphosphonates) as an adjunctive herbal‑mineral combination.
Typical use and precautions
Usual dose is commonly 1 tablet/softgel once daily, preferably with food and at a fixed time, as per physician advice or local OTC‑label guidance.
Avoid or use cautiously in hypercalcaemia, renal stones, severe renal impairment, or concomitant high‑dose calcium/vitamin K therapy; monitor serum calcium and renal function if used long term.
Astemax (via Essendon Formulation) markets Quitcal Total as a bone‑plus‑joint‑support nutraceutical, suitable for physicians and surgeons managing fracture‑healing,
